preliminary analysis of mortality data from the anisoylated plasminogen streptokinase activator complex ( apsac ) intervention mortality study ( aims ) showed a 47 % reduction in 30-day mortality ( with a 95 % confidence interval of 21 to 65 % ) for patients treated with apsac within 6 hours of onset of acute myocardial infarction .
C0078956
apsac
C0027051
myocardial infarction